, Tracking Stock Market Picks
Enter Symbol:
Juno Therapeutics Inc. (JUNO) [hlAlert]


Juno Therapeutics Inc. (JUNO) downgraded to Hold by Standpoint Research

Posted on: Thursday,  Oct 29, 2015  10:25 AM ET by Standpoint Research

Standpoint Research rated Hold Juno Therapeutics Inc. (NASDAQ: JUNO) on 10/29/2015. Previously Standpoint Research rated Buy Juno
Therapeutics Inc. (NASDAQ: JUNO) on 08/24/2015., when the stock price was $37.29. Since then, Juno Therapeutics Inc. has gained 41.24% of its value until Standpoint Research rated JUNO Buy on 10/29/2015, when the price was $52.67. .

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2015 2:25 PM Buy
as of 8/27/2015
1 Week up  0.10 %
1 Month   
3 Months   
1 YTD up  0.10 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2015 10:25 AM Hold
8/24/2015 10:25 AM Buy
37.29 47.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy